You can purchase shares of Lycia Therapeutics (NASDAQ:LYCA) through any online brokerage.
There are no as such competitors for Lycia Therapeutics.
There is no analysis for Lycia Therapeutics to provide a consensus price target.
The stock price for Lycia Therapeutics (NASDAQ: LYCA) is $26.9 last updated October 23, 2026 at 6:46 PM EDT.
There are no upcoming dividends for Lycia Therapeutics.
Lycia Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Lycia Therapeutics.
Lycia Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of novel therapeutics designed to degrade disease-causing extracellular proteins, with an initial focus on addressing autoimmune, inflammatory...